Endovascular Treatment for Femoropopliteal Arterial Lesions with a Focus on Long-Term Limb Prognosis

Area of Science:

• Vascular Surgery
• Interventional Cardiology
• Endovascular Therapy

Background:

• Femoropopliteal (FP) arterial lesions are common and difficult targets in lower extremity artery disease (LEAD).
• Endovascular therapy (EVT) for FP lesions is limited by high rates of restenosis and occlusion.
• Current evidence lacks definitive proof of superiority for any specific EVT device strategy in FP artery disease.

Purpose of the Study:

• To review the current landscape of endovascular therapy for femoropopliteal arterial lesions.
• To highlight the persistent challenges of restenosis and occlusion in FP interventions.
• To underscore the need for further research into optimal device strategies for LEAD.

Main Methods:

• Review of existing literature on endovascular treatment of femoropopliteal lesions.
• Analysis of factors contributing to restenosis and occlusion post-EVT.
• Evaluation of the impact of lesion characteristics on intervention outcomes.

Main Results:

• Femoropopliteal lesions remain a primary challenge in lower extremity artery disease management.
• High rates of restenosis and occlusion persist despite technological advancements in EVT.
• Stent restenosis is associated with longer lesions and increased occlusive failure, complicating reintervention.

Conclusions:

• No single endovascular device strategy has proven superior for femoropopliteal artery disease.
• Restenosis and occlusion significantly limit the long-term success of EVT in the FP segment.
• Further research is crucial to improve outcomes and reinterventional feasibility in complex FP lesions.